Anthropic to raise $2 billion in deal valuing AI startup at $60 billion, WSJ says
(Reuters) -AI startup Anthropic is in advanced talks to raise $2 billion in a deal valuing the OpenAI rival at $60 billion, the Wall Street Journal reported on Tuesday, citing people familiar with the matter.
Anthropic’s $60 billion valuation would obscure a stark reality in AI
Anthropic may be joining rival OpenAI with its own eye-popping valuation, but the hefty valuations for the two biggest AI startups obscure the fact that, for now, these companies are burning through billions in cash.
A.I. Start-Up Anthropic Is in Talks That Could Value It at $60 Billion
The financing efforts follow new funding rounds by Elon Musk’s xAI and the market leader, OpenAI, which is now valued at $157 billion.
AI startup Anthropic to raise $2 billion at $60 billion valuation, sources say
AI startup Anthropic is near a deal to raise an additional $2 billion at a price that values the company at $60 billion, sources said, months after its $4 billion funding from Amazon .
Anthropic in Talks to Raise Funding at $60 Billion Value
OpenAI rival Anthropic is in advanced talks to raise $2 billion in a funding round that would value the startup at $60 billion, according to two people familiar with the matter.
AI start-up Anthropic closes in on $60bn valuation
Maker of the Claude AI chatbot nears fresh $2bn investment in the latest sign of how much money is pouring into the sector
Anthropic reaches deal on AI 'guardrails' in lawsuit over music lyrics
Artificial intelligence company Anthropic has reached an agreement with Universal Music and other music publishers over its ...
Getty Deal Is Picture-Perfect M&A For 2025
Getty Images’ $3.7 billion merger, including debt, with rival stock image seller Shutterstock is a picture-perfect template ...
Shutterstock and Getty Merge to Meet AI Challenge in $3.7 Billion Deal
The two big players in the licensed visual content will pair up to counter threats from artificial intelligence tools like Midjourney.
AMD is going head-to-head with Nvidia in AI-backed drug discovery with new deal
Chip maker AMD is investing $20 million in AI drug startup Absci, which will use AMD chips and software for drug development.
CNET on MSN7h
Nvidia Hands-Down Won AI At CES 2025. Here's Why That Matters
In early January of 2023, Nvidia stock hovered around $15. With the AI revolution, companies have been scrambling to buy Nvidia chips over the past two years to power their servers. After Huang's ...
Anthropic Deal Would Be the Latest to Seize Upon AI Euphoria
A new funding round valuing artificial-intelligence startup Anthropic at $60 billion would amp up the dealmaking frenzy in AI. Among the recent notable investments: Data-analytics company Databricks l ...
Get AI and all-day battery life for more than $170 off with this deal on the Google Pixel 9.
With AI and all-day battery life among its features, the Pixel 9 is Google's most affordable flagship phone, and it's even ...
CRN2d
AMD Wins Over Dell In Commercial PC Deal For Ryzen AI Pro Chips
AMD said it has won its first deal to supply Ryzen AI Pro chips to commercial PCs made by Dell Technologies, opening another ...
Paychex to buy rival Paycor in $4.1 billion deal to expand AI-driven HR products
Paychex said on Tuesday it will acquire payroll processing firm Paycor HCM for about $4.1 billion in cash, as the HR ...